A groundbreaking blood test could one day identify healthy older adults at high risk of developing Alzheimer's symptoms years before memory loss begins, offering scientists a powerful new tool in the quest to halt the disease's progression.
Researchers announced on Wednesday that individuals with the highest levels of a blood marker called p-tau217 faced a 38% probability of developing cognitive impairment within five years, escalating to a 78% chance within a decade.
